OCTOBER 21-23, 2024 | BETHESDA NORTH MARRIOTT HOTEL & CONFERENCE CENTER, ROCKVILLE, MD

EXPLORE INNOVATIONS FROM GENERICS AND BIOSIMILARS

GRx+Biosims™ 2024 is the premier regulatory science and policy event for the U.S. generics and biosimilars industry. Access the most recent information straight from experts at the Food and Drug Administration, grasp the latest policies shaping the industry, and acquire valuable insights to propel your professional development.

BE INFORMED +
GAIN INSIGHTS

Bench scientists and technical professionals can gain insights from drug regulators to help expedite approvals and speed to market, and learn about the latest innovations and emerging technology. Policy professionals, industry professionals and regulators have the opportunity to network with others in the industry and gain a fuller understanding of how regulations affect the real world. In addition, connect with global influencers, increase your knowledge base to stay on the cutting edge and learn about best practices to enhance your organization’s overall performance.

GRx+Biosims 2023, North Bethesda, MD

GRx+Biosims 2022, North Bethesda, MD

CONNECT + ENGAGE

Join us at GRx+Biosims 2024 on October 21-23, 2024. This conference offers three days of networking opportunities and thought-provoking discussions on key issues impacting the generics and biosimilars industry. Our program is designed to inspire and inform, featuring insights from industry leaders and experts.

Why You Should Attend

Network with speakers, attendees, exhibitors and sponsors

Get access to the latest information about U.S. generics and biosimilars

Gain expert insights on implementation of the latest regulations, guidances, case law, current health authority processes and practices and policy

Learn how legislation related to the generics and biosimilars industry can impact patient access to more affordable medicines

Make more informed decisions by better understanding FDA’s expectations and current thinking on processes, practice and policy

Attend this one-stop-shop for all your U.S. generics and biosimilars industry policy, regulatory and scientific needs

Join us for a special session reflecting on the remarkable career of Dr. Janet Woodcock, who recently retired from the U.S. Food and Drug Administration after 38 years of service. Dr. Woodcock been called one of the most powerful and influential drug regulators who has left a historic mark on the pharmaceutical industry and public health.
This session, hosted by Women in Health Policy (WiHP) and powered by the Association for Accessible Medicines (AAM), will dive into Dr. Woodcock’s impactful contributions to the generic and biosimilars industry and her legacy within the FDA. We will discuss her leadership, achievements, and the lasting impact of her work on drug regulation and accessibility.

Janet Woodcock, M.D.

Former Principal Deputy Commissioner, FDA

Speaker Highlights

Craig Burton

Senior Vice President, Policy and Strategic Alliances, AAM
Executive Director, Biosimilars Council

Keren Haruvi

Board Chair
Association for Accessible Medicines (AAM)

Iilun Murphy, M.D.

Director
Office of Generic Drugs (OGD), CDER FDA

Jacqueline Corrigan-Curray, JD, M.D.

Principal Deputy Center Director
Center for Drug Evaluation and Research (CDER), FDA

EXPO

Showcase your company at GRx+Biosims 2024. Don’t miss out on this highly interactive and professional business environment in which industry vendors can meet generics and biosimilars industry executives. We offer our exhibitors abundant networking time with industry decision-makers. To learn more, email Aquera Agee.

GRX+BIOSIMS 2024
SOCIAL MEDIA TOOLKIT

STAY INFORMED WITH THE MOST RECENT UPDATES

Access up-to-date event details, including information about prominent speakers, sponsorship options, and exhibition opportunities.